Idexx Laboratories G&A increased by 9.7% to $119.12M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 30.1%, from $91.56M to $119.12M. Over 4 years (FY 2021 to FY 2025), G&A shows an upward trend with a 6.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Rising G&A as a percentage of revenue may indicate organizational bloat, while stability suggests effective cost management.
General and administrative expenses cover the overhead costs of running the business, including executive salaries, lega...
Standard operating expense category; used to assess administrative leverage.
general_and_administrative| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $73.33M | $82.10M | $83.47M | $77.95M | $81.49M | $83.76M | $83.05M | $70.10M | $89.67M | $89.03M | $87.02M | $92.02M | $157.24M | $91.89M | $101.14M | $91.56M | $98.68M | $105.94M | $108.62M | $119.12M |
| QoQ Change | — | +12.0% | +1.7% | -6.6% | +4.5% | +2.8% | -0.9% | -15.6% | +27.9% | -0.7% | -2.3% | +5.7% | +70.9% | -41.6% | +10.1% | -9.5% | +7.8% | +7.4% | +2.5% | +9.7% |
| YoY Change | — | — | — | — | +11.1% | +2.0% | -0.5% | -10.1% | +10.0% | +6.3% | +4.8% | +31.3% | +75.4% | +3.2% | +16.2% | -0.5% | -37.2% | +15.3% | +7.4% | +30.1% |